← Back
Data updated: Mar 10, 2026
CHANGZHOU PHARM
CardiovascularInfectious Disease
CHANGZHOU PHARM is a generic drug manufacturer focused on Cardiovascular, Infectious Disease.
2016
Since
4
Drugs
-
Trials
216
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
PREGABALIN 2026-02-24
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
DOXYCYCLINE HYCLATE 2026-02-19
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
TICAGRELOR 2026-02-06
PREGABALIN 2026-02-03
Labeling
PREGABALIN 2026-02-02
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 67%
2 drugs
Infectious Disease 33%
1 drugs
Pipeline Strength Pro
Loading...
Active (3)
Discontinued (1)
Company Info
- First Approval
- 2016-10-31
- Latest
- 2026-02-02
- Applications
- 5